Background. Pulmonary nocardiosis is an infection targeting immunocompromised patients characterized by high mortality and requires nonfrontline antibiotics for treatment. Nocardiosis is currently confirmed or excluded by BAL fluid culture followed by further phenotypic identification steps. A culture-independent method with more timely results would accelerate the administration of appropriate treatment. A rapid Nocardia (NOC) PCR assay for BAL has neither been previously validated nor offered for clinical testing to our knowledge.
Background. Historically, increases in blood culture (BC) fill volumes (FVs) have been shown to increase yield of BCs and lower contamination rates. Low FV are a common cause of false negative BCs. 10 mL is considered an ideal FV for a BC. In 2015 and 2016, at North Shore University Hospital, FVs averaged <5 mL per BC. In 2017, several interventions were implemented to increase FVs, including convening informal meetings and seminars to educate nursing staff, educational phlebotomy posters, placing 10-mL markings on BC bottles and using butterfly catheters and tabletops for collection. Our aim was to assess trends in overall yield (OY), contaminants and FVs.
Methods. Average FVs, positive BC quantities and organism identification were obtained from 2015 through 2017. Contaminants included bacillus, corynebacterium, coagulase negative staphylococcus, micrococcus and single sets of α-hemolytic streptococcus. OY was the number of positive sets, excluding contaminants, divided by the total number of BCs. Subgroup yield (SY) was the number of positive sets in a subgroup divided by the total number of BCs. Trends in OY, SY, and contaminants were assessed using the Cochran Armitage Trend test. The one-way ANOVA test was used to assess differences between FVs by year.
Results. OY increased over the 2015-2017 period (Table 1 ; P < 0.0001). All SYs increased except for staphylococcus and anaerobes. Contaminants did not show a decreasing trend (Table 2 ; P = 0.9002). Background. One day incubation time for non-invasive urine cultures makes the lab operation and work flow more efficient. However, it has been a matter of debate since striking a balance between potential loss of slow-growing pathogenic organisms weighs heavily over shorter incubation time. Our study at Sutter Health Shared Laboratory (SHSL) evaluated the possibility of significant loss of uropathogens, if cultures incubated for only one day in CO2 and examined using a benchtop magnifier, and compared it with 2 days incubation.
Methods. Only routinely collected urine cultures has been included in this study and invasive collection such as nephrostomy, straight or diagnostic catheter collection were excluded. SHSL urine culture procedure defines the workup cut off for uropathognic organisms in a routine culture as 10,000 CFU/mL. Total of 2,709 urine specimens were processed using WASP automated plating system. 1 µL sterile loops were used to inoculate BAP/MAC bi-plates. Plates were incubated in 5% CO 2 at 35⁰C for at least 18 hours and maximum 24 hours for the first day evaluation. All no-growth plates were examined with a regular bench top magnifier/light for evidence of growth, and if verified, they were incubated for an extra day of incubation. Organism identifications performed by Vitek MS instrument.
Results. Total of 501 out of 2,709 samples were determined No-Growth on the first day examination, and after second day of incubation 435 stayed as No-Growth (86.8%), 66 samples (13.2%) indicate growth of normal Uro-Genital (UG) microbiota, and no uropathognic organisms detected. Among those with growth 54 (10.8%) samples grew <10K, 10 samples (2.0%) grew 10-50K, and 2 samples (0.4% [95% CI= 0.1% -1.5%]) grew >50K CFU/mL of normal UG microbiota.
Conclusion. Although small percentage with low level urogenital microbiota was missed on the first day of incubation, there were no uropathogenic organisms missed. Therefore, the 1-day incubation of routine urine culture plates in CO 2 , and careful examination of the plates appeared to have same efficiency of 2-day incubation in pathogen detection. One-day incubation can result in workflow efficiency, significant saving in labor and incubation space for large volume laboratories, or laboratories with total microbiology automation.
Disclosures. All authors: No reported disclosures. Background. Urinary antigen testing for Streptococcus pneumoniae (PAgT) is simple, rapid, and can still be used days after initiation of antibiotic therapy or when conventional methods are failing. PAgT is recommended by international guidelines in severe community acquired pneumonia (CAP). The test attains an excellent specificity (>90%) in adults but shows a varying sensitivity (60-85%). We aimed to analyze the PAgT sensitivity in a population with blood culture proven invasive pneumococcal disease (IPD) and to study its performance for the different pneumococcal serotypes.
Performance of Pneumococcal Urinary
Methods. PAgT (BinaxNOW®, Alere®) was introduced in 2009 in a large secondary care hospital in Ghent, Belgium. PAgT is requested by the attending physician or the clinical microbiologist in case of IPD suspicion. Pneumococci from blood are identified by standard methods (optochin susceptibility and bile solubility) and serotyped by the national reference center. Overall PAgT performance and test sensitivity for different serotypes were calculated.
Results. Over a 9-year period, (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) , 235 bacteremia episodes in 234 patients were observed with an average of 26 episodes/year (range 12-36). 31/235 (13%) episodes occurred in pediatric patients. Most prevalent serotypes were 1, 12, 8, 3, 7, 9, 5 , and 6 for the whole time period. PAgT was performed in 161/235 (69%), test execution for the individual most prevalent serotypes ranged from 55 to 86%. 99/161(61%) PAgT were positive. PAgT positive results varied according to the most prevalent serotypes: >70% for types 1, 3, 7and 5, 50% for type 9 and <50% for types 12, 8 and 6. From 2014 on, disappearance of serotype 1 and a significant decrease in serotype 7 were observed.
Conclusion. A 70% compliance to the diagnostic algorithm for IPD was observed. PAgT detects C-polysaccharide (teichoic acid) on the pneumococcal cell wall. Differences in concentration for the individual serotypes have been described and may account for the varying sensitivity in our dataset. Introduction of 10/13-valent childhood pneumococcal vaccines (2014) in Belgium has changed the overall serotype distribution, also possibly leading to a shift in PAgT performance. A dynamic validation of PAgT accuracy remains warranted.
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